Arrestee Drug Abuse Monitoring
Arrestee Drug Abuse Monitoring, or ADAM, was a survey conducted by the U.S. Department of Justice to gauge the prevalence of alcohol and illegal drug use among prior arrestees. It was a reformulation of the prior Drug Use Forecasting (DUF) program, focused on five drugs in particular: cocaine, marijuana, methamphetamine, opiates, and PCP.
Methodology
Participants were randomly selected from arrest records in major metropolitan areas; because no personally identifying information is taken from each record chosen, the resulting data can be correlated to arrest rates, but not to the total population of persons charged.
ADAM began as the Drug Use Forecasting program in 1987, which tested arrestees in 13 (later 23) jurisdictions on a quarterly basis. In 1991, juvenile data was added for the first time, at select sites. In 1996, President Clinton requested that the program be expanded, as ADAM, by tripling the size to 75 metropolitan areas and adding an outreach component for non-metropolitan offenders, as a scientific control. At most, 42 jurisdictions ever participated in the program at one time.
Information was obtained from personal interviews and urine analysis obtained voluntarily and confidentially, usually on the day of arrest and always within 48 hours of arrest.
Under DUF, both male and female subjects were selected on a random basis. When ADAM was fully implemented in 2000, a different methodology was adopted, whereby male subjects were chosen at random and female subjects were chosen where available (not all participating sites have sufficient numbers of women arrestees to be statistically sound; ADAM defined this as 25 women available to be interviewed). In addition, the interview portion of the ADAM program was expanded to cover behaviors and drug use that could not be tested for by urinalysis, such as alcohol abuse. The catchment areas were redefined, from metropolitan area/city limits to county boundaries, in order to help standardize the data.
Cancellation
On January 29, 2004, the ADAM program was halted due to funding concerns; government sources state that a revised program was to be implemented in late 2005[1]. The program was reimplemented in 2007 funded by ONDCP and run by Abt Associates. ONDCP continued the program in 10 of the original site until 2014. Results can be seen on the ONDCP website.
Testing areas
These sites were used at some or all points of the DUF/ADAM studies as testing areas. Some of the smaller locations such as Woodbury County, Iowa and Rio Arriba, New Mexico were added late in the program's life, in an attempt to gain information about non-metropolitan areas. In 2007 tenof the original sites continued: NYC, Chicago, Washington DC, Denver, Charlotte, Indianapolis, Sacramento, Portland, Minneapolis, Atlanta. In the last two years of operation the program continued in five of these sites: Denver, Sacramento, NYC, Atlanta,Chicago.
- Albany, NY
- Albuquerque, NM
- Anchorage, AK
- Atlanta, GA
- Birmingham, AL
- Boston, MA
- Charlotte, North Carolina
- Chicago, IL
- Cleveland, OH
- Dallas, TX
- Denver, CO
- Des Moines, IA
- Detroit, MI
- Ft. Lauderdale, FL
- Honolulu, HI
- Houston, TX
- Indianapolis, IN
- Laredo, TX
- Los Angeles
- Las Vegas, NV
- Miami, FL
- Minneapolis, MN
- New Orleans, LA
- Manhattan, NY (New York City)
- Oklahoma City, OK
- Omaha, NE
- Philadelphia, PA
- Phoenix, AZ
- Portland, OR
- Rio Arriba County, NM
- Sacramento, CA
- Salt Lake City, UT
- San Antonio, TX
- San Diego, CA
- San Jose, CA
- Seattle, WA
- Spokane, WA
- St. Louis, MO
- Tampa, FL
- Tucson, AZ
- Tulsa, OK
- Washington, D.C.
- Woodbury County, IA
External links
- Official ADAM website, with reports
- Press release from DUF's reformulation into ADAM, including the expansion to 35 sites